Rutin (quercetin rutinoside) induced protein-energy malnutrition in chronic kidney disease, but quercetin acted beneficially

Chiu Lan Hsieh, Chiung Chi Peng, Kuan Chou Chen, Robert Y. Peng

研究成果: 雜誌貢獻文章

11 引文 (Scopus)

摘要

Nutraceutically, much of the literature has indicated that an aglycon and its related glycoside would act similarly. However, controversial reports are accumulating. We hypothesize that rutin (RT) and quercetin (QT) pharmacodynamically could act differently. To confirm this, doxorubicin (DR) (8.5 mg/kg) was used to induce rat chronic kidney disease (CKD) and then treated with QT and RT (each 70 mg/kg body weight per day) for 13 weeks. QT exhibited better body weight gaining effect (420 ± 45) vs RT, 350 ± 57 g/rat (p <0.001). DR raised the ratio kidney-to-body weight (%) to 0.82 (p <0.001) vs RT, 0.62 (p <0.01), and QT, 0.35 (p <0.01). DR reduced the glomerular filtration rate to 25.2 vs RT, 48 ± 11.3; QT, 124.7 ± 12.8 (p <0.001) and the control, 191.5 ± 15.7 mL/h (p <0.001). DRCKD reduced hematocrit to 29 ± 5; RT, to 28 ± 5 (p <0.05); QT, to 36 ± 6 vs the control 37.5 ± 4%, (p <0.01). DRCKD reduced the serum albumin (s-Ab) to 2.1 ± 0.2 (p <0.001); QT, to 2.7 ± 0.2 (p <0.05) vs the normal 4.3 ± 0.5 g/dL, yet RT was totally ineffective. DRCKD raised serum cholesterol level to 340 ± 30; vs RT, 260 ± 12; QT, 220 ± 25; and the normal value, 70 ± 25 mg/dL. DRCKD increased serum triglyceride to 260 ± 15 (p <0.001), RT and QT restored it to 170 ± 25 and 200 ± 15 (p <0.05) vs the normal 26-145 mg/dL. DRCKD elevated blood urea nitrogen to 38 ± 3 vs RT, to 98 ± 6 mg/dL (p <0.001), implicating "protein-energy malnutrition". RT stimulated serum creatinine (sCr) production to reach 6.0 ± 0.9 mg/dL (p <0.001). QT did not alter the sCr level. RT but not QT induced uremia and hypercreatininemia. DR significantly downregulated Bcl-2, but highly upregulated Bax, Bad, and cleaved caspase-3, implicating the intrinsic mitochondrial pathway. DR damaged DNA, but QT completely rescued such an effect and recovered renal amyloidosis and collagen deposition. Conclusively, RT and QT act differently, and RT is inferior to QT with respect to treating CKD.

原文英語
頁(從 - 到)7258-7267
頁數10
期刊Journal of Agricultural and Food Chemistry
61
發行號30
DOIs
出版狀態已發佈 - 七月 31 2013

指紋

Protein-Energy Malnutrition
Rutin
protein energy malnutrition
Quercetin
rutin
kidney diseases
Chronic Renal Insufficiency
quercetin
doxorubicin
Proteins
Doxorubicin
blood serum
Body Weight
Serum
creatinine
body weight
Rats
Creatinine
kidneys
Kidney

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Chemistry(all)

引用此文

@article{2e7dc769e46841419c8c01211f4d0cff,
title = "Rutin (quercetin rutinoside) induced protein-energy malnutrition in chronic kidney disease, but quercetin acted beneficially",
abstract = "Nutraceutically, much of the literature has indicated that an aglycon and its related glycoside would act similarly. However, controversial reports are accumulating. We hypothesize that rutin (RT) and quercetin (QT) pharmacodynamically could act differently. To confirm this, doxorubicin (DR) (8.5 mg/kg) was used to induce rat chronic kidney disease (CKD) and then treated with QT and RT (each 70 mg/kg body weight per day) for 13 weeks. QT exhibited better body weight gaining effect (420 ± 45) vs RT, 350 ± 57 g/rat (p <0.001). DR raised the ratio kidney-to-body weight ({\%}) to 0.82 (p <0.001) vs RT, 0.62 (p <0.01), and QT, 0.35 (p <0.01). DR reduced the glomerular filtration rate to 25.2 vs RT, 48 ± 11.3; QT, 124.7 ± 12.8 (p <0.001) and the control, 191.5 ± 15.7 mL/h (p <0.001). DRCKD reduced hematocrit to 29 ± 5; RT, to 28 ± 5 (p <0.05); QT, to 36 ± 6 vs the control 37.5 ± 4{\%}, (p <0.01). DRCKD reduced the serum albumin (s-Ab) to 2.1 ± 0.2 (p <0.001); QT, to 2.7 ± 0.2 (p <0.05) vs the normal 4.3 ± 0.5 g/dL, yet RT was totally ineffective. DRCKD raised serum cholesterol level to 340 ± 30; vs RT, 260 ± 12; QT, 220 ± 25; and the normal value, 70 ± 25 mg/dL. DRCKD increased serum triglyceride to 260 ± 15 (p <0.001), RT and QT restored it to 170 ± 25 and 200 ± 15 (p <0.05) vs the normal 26-145 mg/dL. DRCKD elevated blood urea nitrogen to 38 ± 3 vs RT, to 98 ± 6 mg/dL (p <0.001), implicating {"}protein-energy malnutrition{"}. RT stimulated serum creatinine (sCr) production to reach 6.0 ± 0.9 mg/dL (p <0.001). QT did not alter the sCr level. RT but not QT induced uremia and hypercreatininemia. DR significantly downregulated Bcl-2, but highly upregulated Bax, Bad, and cleaved caspase-3, implicating the intrinsic mitochondrial pathway. DR damaged DNA, but QT completely rescued such an effect and recovered renal amyloidosis and collagen deposition. Conclusively, RT and QT act differently, and RT is inferior to QT with respect to treating CKD.",
keywords = "apoptosis, chronic kidney disease, flavonol, hypercreatininemia, quercetin, rutin",
author = "Hsieh, {Chiu Lan} and Peng, {Chiung Chi} and Chen, {Kuan Chou} and Peng, {Robert Y.}",
year = "2013",
month = "7",
day = "31",
doi = "10.1021/jf304595p",
language = "English",
volume = "61",
pages = "7258--7267",
journal = "Journal of Agricultural and Food Chemistry",
issn = "0021-8561",
publisher = "American Chemical Society",
number = "30",

}

TY - JOUR

T1 - Rutin (quercetin rutinoside) induced protein-energy malnutrition in chronic kidney disease, but quercetin acted beneficially

AU - Hsieh, Chiu Lan

AU - Peng, Chiung Chi

AU - Chen, Kuan Chou

AU - Peng, Robert Y.

PY - 2013/7/31

Y1 - 2013/7/31

N2 - Nutraceutically, much of the literature has indicated that an aglycon and its related glycoside would act similarly. However, controversial reports are accumulating. We hypothesize that rutin (RT) and quercetin (QT) pharmacodynamically could act differently. To confirm this, doxorubicin (DR) (8.5 mg/kg) was used to induce rat chronic kidney disease (CKD) and then treated with QT and RT (each 70 mg/kg body weight per day) for 13 weeks. QT exhibited better body weight gaining effect (420 ± 45) vs RT, 350 ± 57 g/rat (p <0.001). DR raised the ratio kidney-to-body weight (%) to 0.82 (p <0.001) vs RT, 0.62 (p <0.01), and QT, 0.35 (p <0.01). DR reduced the glomerular filtration rate to 25.2 vs RT, 48 ± 11.3; QT, 124.7 ± 12.8 (p <0.001) and the control, 191.5 ± 15.7 mL/h (p <0.001). DRCKD reduced hematocrit to 29 ± 5; RT, to 28 ± 5 (p <0.05); QT, to 36 ± 6 vs the control 37.5 ± 4%, (p <0.01). DRCKD reduced the serum albumin (s-Ab) to 2.1 ± 0.2 (p <0.001); QT, to 2.7 ± 0.2 (p <0.05) vs the normal 4.3 ± 0.5 g/dL, yet RT was totally ineffective. DRCKD raised serum cholesterol level to 340 ± 30; vs RT, 260 ± 12; QT, 220 ± 25; and the normal value, 70 ± 25 mg/dL. DRCKD increased serum triglyceride to 260 ± 15 (p <0.001), RT and QT restored it to 170 ± 25 and 200 ± 15 (p <0.05) vs the normal 26-145 mg/dL. DRCKD elevated blood urea nitrogen to 38 ± 3 vs RT, to 98 ± 6 mg/dL (p <0.001), implicating "protein-energy malnutrition". RT stimulated serum creatinine (sCr) production to reach 6.0 ± 0.9 mg/dL (p <0.001). QT did not alter the sCr level. RT but not QT induced uremia and hypercreatininemia. DR significantly downregulated Bcl-2, but highly upregulated Bax, Bad, and cleaved caspase-3, implicating the intrinsic mitochondrial pathway. DR damaged DNA, but QT completely rescued such an effect and recovered renal amyloidosis and collagen deposition. Conclusively, RT and QT act differently, and RT is inferior to QT with respect to treating CKD.

AB - Nutraceutically, much of the literature has indicated that an aglycon and its related glycoside would act similarly. However, controversial reports are accumulating. We hypothesize that rutin (RT) and quercetin (QT) pharmacodynamically could act differently. To confirm this, doxorubicin (DR) (8.5 mg/kg) was used to induce rat chronic kidney disease (CKD) and then treated with QT and RT (each 70 mg/kg body weight per day) for 13 weeks. QT exhibited better body weight gaining effect (420 ± 45) vs RT, 350 ± 57 g/rat (p <0.001). DR raised the ratio kidney-to-body weight (%) to 0.82 (p <0.001) vs RT, 0.62 (p <0.01), and QT, 0.35 (p <0.01). DR reduced the glomerular filtration rate to 25.2 vs RT, 48 ± 11.3; QT, 124.7 ± 12.8 (p <0.001) and the control, 191.5 ± 15.7 mL/h (p <0.001). DRCKD reduced hematocrit to 29 ± 5; RT, to 28 ± 5 (p <0.05); QT, to 36 ± 6 vs the control 37.5 ± 4%, (p <0.01). DRCKD reduced the serum albumin (s-Ab) to 2.1 ± 0.2 (p <0.001); QT, to 2.7 ± 0.2 (p <0.05) vs the normal 4.3 ± 0.5 g/dL, yet RT was totally ineffective. DRCKD raised serum cholesterol level to 340 ± 30; vs RT, 260 ± 12; QT, 220 ± 25; and the normal value, 70 ± 25 mg/dL. DRCKD increased serum triglyceride to 260 ± 15 (p <0.001), RT and QT restored it to 170 ± 25 and 200 ± 15 (p <0.05) vs the normal 26-145 mg/dL. DRCKD elevated blood urea nitrogen to 38 ± 3 vs RT, to 98 ± 6 mg/dL (p <0.001), implicating "protein-energy malnutrition". RT stimulated serum creatinine (sCr) production to reach 6.0 ± 0.9 mg/dL (p <0.001). QT did not alter the sCr level. RT but not QT induced uremia and hypercreatininemia. DR significantly downregulated Bcl-2, but highly upregulated Bax, Bad, and cleaved caspase-3, implicating the intrinsic mitochondrial pathway. DR damaged DNA, but QT completely rescued such an effect and recovered renal amyloidosis and collagen deposition. Conclusively, RT and QT act differently, and RT is inferior to QT with respect to treating CKD.

KW - apoptosis

KW - chronic kidney disease

KW - flavonol

KW - hypercreatininemia

KW - quercetin

KW - rutin

UR - http://www.scopus.com/inward/record.url?scp=84881055579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881055579&partnerID=8YFLogxK

U2 - 10.1021/jf304595p

DO - 10.1021/jf304595p

M3 - Article

C2 - 23876017

AN - SCOPUS:84881055579

VL - 61

SP - 7258

EP - 7267

JO - Journal of Agricultural and Food Chemistry

JF - Journal of Agricultural and Food Chemistry

SN - 0021-8561

IS - 30

ER -